关闭
About us

ABOUT GAUSH

Over 20 years of dedication to ophthalmology, empowering eye health with a full industrial chain

Company profile

Gaush Meditech Ltd.

Successfully listed on the Main Board of the HKEX on December 12, 2022, Gaush Meditech Ltd. is a leading enterprise committed to advancing patients' eye health. With over 20 years of development, Gaush provides an integrated business offering that covers R&D, manufacturing, sales, training, and technical services for ophthalmic devices.


Research and Development

To maintain long-term competitiveness and stride toward becoming a global ophthalmic total solution provider, Gaush has built a robust innovation network with distinct strengths across the industry:

● Global R&D Footprint: The company operates 2 overseas R&D centers (in the Netherlands and Germany, focusing on premium IOLs and electrophysiological systems) and 5 domestic centers dedicated to developing ophthalmic diagnostic equipment, surgical instruments, consumables, and implants.
● Core R&D Capability: We consistently invest heavily in innovation, In 2025, R&D investment amounted to RMB 92.58 million, representing 21.6% of revenue from proprietary products and marking an 18.1% year-over-year increase. The company has secured a cumulative total of 153 patents and operates an R&D and manufacturing base exceeding 10,000 square meters.


Products Portfolio & Provider Solutions (Distribution )

As a provider of a broad spectrum of ophthalmic medical devices, Gaush offers economic, customized, and integrated solutions designed to lower overall customer costs and facilitate comprehensive, patient-centered vision care.

● Rich Product Portfolio: With over 153 types of products,of which 74 are self-developed,we cover all 4 major dimensions of ophthalmic devices (diagnosis, treatment, instruments, consumables) across 7 sub-specialties (Retinal Disease, Cataract, Glaucoma, Refractive Surgery, Optometry, Ocular Surface / Corneal Disease, and Pediatric Ophthalmology).
● International Partnerships: Built on professionalism and integrity, Gaush serves as the exclusive China market partner for 16 globally influential ophthalmic brands from Germany, the US, and beyond. We seamlessly connect China’s ophthalmic industry with global standards, support efficient product registration for our partners, and provide valuable clinical feedback from domestic doctors to drive further innovation.


Service Network

Driven by the core value of "Customer First," Gaush has developed a highly reputable, multi-faceted distribution and service system:

● Extensive Distribution: We supply our products to over 4,000 end customers across China, including 1,000+ Class III hospitals.

● Gaush Service: A dedicated technical support team of 133 engineers,—averaging 10+ years of experience—is strategically stationed across 30+ provinces. They deliver over 29,000 technical services annually with fast response times and reliable quality.
● Gaush Online (G-Webinar): As the premier online professional education platform designed for ophthalmologists and optometrists, it provides robust clinical and academic support to a community of over 60,000 followers.



Guash Culture

  • Our Core Values
    Our Core Values

    Customer Orientation・Dedication・Integrity
    Open-mind・Teamwork・Self-reflection



  • Our Vision
    Our Vision

    To become a global leader in the ophthalmic device industry.

  • Our Mission
    Our Mission

    Technology creates a brighter vision.

Gaush Story

  • 1998: Establishment of Gaush

    1998: Establishment of Gaush

    Gaush was founded in Beijing, initially operating as a distributor. By introducing premier international ophthalmic products—such as ophthalmic ultrasound diagnostic systems and OCT devices—into the Chinese market, Gaush brought global-standard technologies to a vast population of ophthalmic patients in China.

  • 2007: Development of the Service Network and Gaush Online

    2007: Development of the Service Network and Gaush Online

    The company established a comprehensive technical service network covering the entirety of China. Concurrently, it launched "Gaush Online" (G-Webinar), creating a professional scientific education platform for the industry.

  • 2017: Acquisition of Raymond

    2017: Acquisition of Raymond

    Gaush embarked on its path of proprietary research and development (R&D), expanding its business into the manufacturing of optometric examination equipment.

  • 2020 & 2021: Acquisitions of Teleon and Roland Consult

    2020 & 2021: Acquisitions of Teleon and Roland Consult

    Gaush acquired Roland Consult in Germany, initiating its strategic global layout in the ophthalmic electrophysiology business.It also acquired Teleon Surgical in the Netherlands, expanding its global footprint into the premium cataract surgery and intraocular lens (IOL) sectors.

  • 2022: HKEX Listing

    2022: HKEX Listing

    Gaush was successfully listed on the Main Board of the Stock Exchange of Hong Kong. Meanwhile, it established multiple R&D bases in China (including Wuxi), continuously bolstering its independent innovation and R&D capabilities.

  • Present: Global Footprint & Internationalization

    Present: Global Footprint & Internationalization

    While maintaining close cooperation with international brand partners, Gaush has been actively driving the global rollout of its self-developed products, committed to bringing Gaush's innovations to patients and healthcare professionals worldwide.

COPYRIGHT©2022-2026 Gaush Meditech Ltd. All Rights Reserved.  Sitemap ICP:ICP 05025558-2